Ondine Biomedical Inc (OBI) — Net Asset Quality Index
Ondine Biomedical Inc (OBI) has a Net Asset Quality Index of 53.6% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX12.82 Million minus total liabilities of GBX5.95 Million yields net assets of GBX6.88 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check OBI asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Ondine Biomedical Inc Net Asset Quality Index Over Time (2001–2024)
This chart shows how Ondine Biomedical Inc's Net Asset Quality Index has evolved across 17 annual periods from 2001 to 2024. As of December 2024, the index stands at 53.6%, representing net assets of GBX6.88 Million against total assets of GBX12.82 Million GBX. See how liquid is Ondine Biomedical Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Ondine Biomedical Inc (2001–2024)
The table below presents the year-by-year Net Asset Quality Index for Ondine Biomedical Inc from 2001 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Ondine Biomedical Inc (OBI) market capitalisation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 53.6% | GBX6.88 Million | GBX12.82 Million | GBX5.95 Million | ▲ +17.3 pp |
| 2023 | 36.4% | GBX2.08 Million | GBX5.73 Million | GBX3.65 Million | ▼ -33.9 pp |
| 2022 | 70.3% | GBX11.64 Million | GBX16.57 Million | GBX4.92 Million | ▼ -16.6 pp |
| 2021 | 86.9% | GBX29.66 Million | GBX34.14 Million | GBX4.48 Million | ▲ +1370.7 pp |
| 2020 | -1283.8% | GBX-33.83 Million | GBX2.63 Million | GBX36.46 Million | ▼ -388.7 pp |
| 2019 | -895.1% | GBX-26.07 Million | GBX2.91 Million | GBX28.99 Million | ▼ -497.1 pp |
| 2018 | -397.9% | GBX-17.90 Million | GBX4.50 Million | GBX22.40 Million | ▼ -281.1 pp |
| 2017 | -116.8% | GBX-6.55 Million | GBX5.61 Million | GBX12.16 Million | ▼ -127.8 pp |
| 2010 | 11.0% | GBX279.19K | GBX2.53 Million | GBX2.25 Million | ▼ -37.8 pp |
| 2009 | 48.8% | GBX1.28 Million | GBX2.62 Million | GBX1.34 Million | ▲ +3.4 pp |
| 2008 | 45.4% | GBX1.34 Million | GBX2.95 Million | GBX1.61 Million | ▼ -38.0 pp |
| 2007 | 83.4% | GBX10.84 Million | GBX13.00 Million | GBX2.16 Million | ▼ -6.5 pp |
| 2006 | 89.9% | GBX16.59 Million | GBX18.46 Million | GBX1.87 Million | ▼ -5.8 pp |
| 2005 | 95.7% | GBX16.50 Million | GBX17.25 Million | GBX745.61K | ▲ +3672.4 pp |
| 2003 | -3576.7% | GBX-227.62K | GBX6.36K | GBX233.99K | ▲ +13319.5 pp |
| 2002 | -16896.2% | GBX-143.28K | GBX848.00 | GBX144.13K | ▼ -16992.2 pp |
| 2001 | 96.0% | GBX1.39 Million | GBX1.45 Million | GBX58.02K | — |